Prot #M11-810: A Phase 3 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects with Moderate to Severe Hidradenitis Suppurativa

  • Gordon, Kenneth B (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date7/24/13 → 7/24/16

Funding

  • AbbVie Inc. (Prot #M11-810)